Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alena Gros

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2015
Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6Lindsey M Draper, Mei Li M Kwong, Alena Gros, et al.
Nature Communications|February 24, 2021
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulationEnrique J Arenas, Alex Martínez-Sabadell, Irene Rius Ruiz, et al.
Human Gene Therapy|June 20, 2012
Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5Lynda Coughlan, Sabari Vallath, Alena Gros, et al.
JCI Insight|October 5, 2018
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapyRami Yossef, Eric Tran, Drew C Deniger, et al.
Science (New York, N.Y.)|October 31, 2015
Immunogenicity of somatic mutations in human gastrointestinal cancersEric Tran, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.
Oncoimmunology|December 21, 2023
Driver mutations in <i>GNAQ</i> and <i>GNA11</i> genes as potential targets for precision immunotherapy in uveal melanoma patientsSandra García-Mulero, Roberto Fornelino, Marco Punta, et al.
Science (New York, N.Y.)|May 10, 2014
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancerEric Tran, Simon Turcotte, Alena Gros, et al.
Cancer Immunology Research|June 30, 2016
Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh TumorAnna Pasetto, Alena Gros, Paul F Robbins, et al.
Cancer Immunology Research|June 18, 2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor AntigensTodd D Prickett, Jessica S Crystal, Cyrille J Cohen, et al.
Nature Medicine|February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsAlena Gros, Maria R Parkhurst, Eric Tran, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2015
Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6Lindsey M Draper, Mei Li M Kwong, Alena Gros, et al.
Nature Communications|February 24, 2021
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulationEnrique J Arenas, Alex Martínez-Sabadell, Irene Rius Ruiz, et al.
Human Gene Therapy|June 20, 2012
Combined fiber modifications both to target α(v)β(6) and detarget the coxsackievirus-adenovirus receptor improve virus toxicity profiles in vivo but fail to improve antitumoral efficacy relative to adenovirus serotype 5Lynda Coughlan, Sabari Vallath, Alena Gros, et al.
JCI Insight|October 5, 2018
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapyRami Yossef, Eric Tran, Drew C Deniger, et al.
Science (New York, N.Y.)|October 31, 2015
Immunogenicity of somatic mutations in human gastrointestinal cancersEric Tran, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.
Oncoimmunology|December 21, 2023
Driver mutations in <i>GNAQ</i> and <i>GNA11</i> genes as potential targets for precision immunotherapy in uveal melanoma patientsSandra García-Mulero, Roberto Fornelino, Marco Punta, et al.
Science (New York, N.Y.)|May 10, 2014
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancerEric Tran, Simon Turcotte, Alena Gros, et al.
Cancer Immunology Research|June 30, 2016
Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh TumorAnna Pasetto, Alena Gros, Paul F Robbins, et al.
Cancer Immunology Research|June 18, 2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor AntigensTodd D Prickett, Jessica S Crystal, Cyrille J Cohen, et al.
Nature Medicine|February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsAlena Gros, Maria R Parkhurst, Eric Tran, et al.
Pageof 5